Not All Tetramer Binding CD8+ T Cells Can Produce Cytokines and Chemokines Involved in the Effector Functions of Virus-Specific CD8+ T Lymphocytes in HIV-1 Infected Children

Chouquet C, Autran B, Gomard E, Bouley JM, Calvez V, Katlama C, : Correlation between breadth of memory HIV-specific cytotoxic T cells, viral load and disease progression in HIV infection. AIDS 16:2399–2407, 2002 Borrow P, Lewicki H, Hahn BH, Shaw GM, Oldstone MB: Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 68:6103–6110, 1994 Koup RA, Safrit JT, Cao Y, Andrews CA, McLeod G, Borkowsky W, : Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 68:4650–4655, 1994 Ogg GS, Kostense S, Klein MR, Jurriaans S, Hamann D, McMichael AJ, : Longitudinal phenotypic analysis of human immunodeficiency virus type 1- specific cytotoxic T lymphocytes: Correlation with disease progression. J Virol 73:9153–9160, 1999 McMichael AJ, Rowland-Jones SL: Cellular immune responses to HIV. Nature 410:980–987, 2001 Buseyne F, Burgard M, Teglas JP, Bui E, Rouzioux C, Mayaux MJ, : Early HIV-specific cytotoxic T lymphocytes and disease progression in children born to HIV-infected mothers. AIDS Res Hum Retroviruses 14:1435–1444, 1998 Buseyne F, Le Chenadec J, Corre B, Porrot F, Burgard M, Rouzioux C, : Inverse correlation between memory gag-specific cytotoxic T lymphocytes and viral replication in human immunodeficiency virus-infected children. J Infect Dis 186:1589–1596, 2002 Carmichael A, Jin X, Sissons P, Borysiewicz L: Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: Differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J Exp Med 177:249–256, 1993 Greenough TC, Brettler DB, Somasundaran M, Panicali DL, Sullivan JL: Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL), virus load, and CD4 T cell loss: Evidence supporting a protective role for CTL in vivo. J Infect Dis 176:118–125, 1997 Klein MR, van Baalen CA, Holwerda AM, Kerkhof Garde SR, Bende RJ, Keet IP, : Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: A longitudinal analysis of rapid progressors and long-term asymptomatics. J Exp Med 181:1365–1372, 1995 Herr W, Protzer U, Lohse AW, Gerken G, Meyer zum Buschenfelde KH, Wolfel T: Quantification of CD8+ T lymphocytes responsive to human immunodeficiency virus (HIV) peptide antigens in HIV-infected patients and seronegative persons at high risk for recent HIV exposure. J Infect Dis 178:260–265, 1998 Larsson M, Jin X, Ramratnam B, Ogg GS, Engelmayer J, Demoitie MA, : A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals. AIDS 13:767–777, 1999 Rininsland FH, Helms T, Asaad RJ, Boehm BO, Tary-Lehmann: Granzyme B ELISPOT assay for ex vivo measurements of T cell immunity. J Immunol Methods 240:143–155, 2000 Wilson JD, Ogg GS, Allen RL, Davis C, Shaunak S, Downie J, : Direct visualization of HIV-1-specific cytotoxic T lymphocytes during primary infection. Aids 14:225–233, 2000 Scott-Algara D, Buseyne F, Blanche S, Rouzioux C, Jouanne C, Romagne F, : Frequency and phenotyping of human immunodeficiency virus (HIV)-specific CD8+ T cells in HIV-infected children, using major histocompatibility complex class I peptide tetramers. J Infect Dis 183:1565–1573, 2001 Buseyne F, Scott-Algara D, Porrot F, Corre B, Bellal N, Burgard M, : Frequencies of ex vivo-activated human immunodeficiency virus type 1-specific gamma-interferon-producing CD8(+) T cells in infected children correlate positively with plasma viral load. J Virol 76:12414–12422, 2002 Buseyne F, Blanche S, Schmitt D, Griscelli C, Riviere Y: Detection of HIV-specific cell-mediated cytotoxicity in the peripheral blood from infected children. J Immunol 150:3569–3581, 1993 Scott ZA, Chadwick EG, Gibson LL, Catalina MD, McManus MM, Yogev R, : Infrequent detection of HIV-1-specific, but not cytomegalovirus-specific, CD8(+) T cell responses in young HIV-1-infected infants. J Immunol 167:7134–7140, 2001 Spiegel HM, Chandwani R, Sheehy ME, Dobroszycki J, Fennelly G, Wiznia A, : The impact of early initiation of highly active antiretroviral therapy on the human immunodeficiency virus type 1-specific CD8 T cell response in children. J Infect Dis 182:88–95, 2000 Appay V, Nixon DF, Donahoe SM, Gillespie GM, Dong T, King A, : HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med 192:63–75, 2000 Goepfert PA, Bansal A, Edwards BH, Ritter GD Jr Tellez I, McPherson SA, : A significant number of human immunodeficiency virus epitope-specific cytotoxic T lymphocytes detected by tetramer binding do not produce gamma interferon. J Virol 74:10249–10255, 2000 Gea-Banacloche JC, Migueles SA, Martino L, Shupert WL, McNeil AC, Sabbaghian MS, : Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term nonprogressors. J Immunol 165:1082–1092, 2000 Goulder PJ, Tang Y, Brander C, Betts MR, Altfeld M, Annamalai K, : Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children. J Exp Med 192:1819–1832, 2000 Hel Z, Nacsa J, Kelsall B, Tsai WP, Letvin N, Parks RW, : Impairment of Gag-specific CD8(+) T-cell function in mucosal and systemic compartments of simian immunodeficiency virus mac251- and simian-human immunodeficiency virus KU2-infected macaques. J Virol 75:11483–11495, 2001 Kern F, Khatamzas E, Surel I, Frommel C, Reinke P, Waldrop SL, : Distribution of human CMV-specific memory T cells among the CD8pos subsets defined by CD57, CD27, and CD45 isoforms. Eur J Immunol 29:2908–2915, 1999 Shankar P, Russo M, Harnisch B, Patterson M, Skolnik P, Lieberman J: Impaired function of circulating HIV-specific CD8(+) T cells in chronic human immunodeficiency virus infection. Blood 96:3094–3101, 2000 Kostense S, Ogg GS, Manting EH, Gillespie G, Joling J, Vandenberghe K, : High viral burden in the presence of major HIV-specific CD8(+) T cell expansions: Evidence for impaired CTL effector function. Eur J Immunol 31:677–686, 2001 Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A: Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401:708–712, 1999 Lieberman J, Shankar P, Manjunath N, Andersson J: Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection. Blood 98:1667–1677, 2001 Zanovello P, Vallerani E, Biasi G, Landolfo S, Collavo D: Monoclonal antibody against IFN-gamma inhibits moloney murine sarcoma virus-specific cytotoxic T lymphocyte differentiation. J Immunol 140:1341–1344, 1998 Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, : CC CKR5: A RANTES, MIP-1alpha MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272:1955–1958, 1996 Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P: Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 270:1811–1815, 1995 Feng Y, Broder CC, Kennedy PE, Berger EA: HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272:872–877, 1996 Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, : Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661–666, 1996 Hadida F, Vieillard V, Autran B, Clark-Lewis I, Baggiolini M, Debre P: HIV-specific T cell cytotoxicity mediated by RANTES via the chemokine receptor CCR3. J Exp Med 188:609–614, 1998 Wasik TJ, Wierzbicki A, Whiteman VE, Trinchieri G, Lischner HW, Kozbor D: Association between HIV-specific T helper responses and CTL activities in pediatric AIDS. Eur J Immunol 30:117–127, 2000 CDC 1994: Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR Recomm Rep 43:1–10, 1994 Mulder J, Resnick R, Saget B, Scheibel S, Herman S, Payne H, : A rapid and simple method for extracting human immunodeficiency virus type 1 RNA from plasma: Enhanced sensitivity. J Clin Microbiol 35:1278–1280, 1997 Krausa P, Brywka M III, Savage D, Hui KM, Bunce M, Ngai JL, : Genetic polymorphism within HLA-A*02: significant allelic variation revealed in different populations. Tissue Antigens 45:223–231, 1995 Kostense S, Vandenberghe K, Joling J, Van Baarle D, Nanlohy N, Manting E, : Persistent numbers of tetramer+ CD8(+) T cells, but loss of interferon-gamma+ HIV-specific T cells during progression to AIDS. Blood 99:2505–2511, 2002 Wedemeyer H, He XS, Nascimbeni M, Davis AR, Greenberg HB, Hoofnagle JH, : Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol 169:3447–3458, 2002 Sandberg JK, Fast NM, Nixon DF: Functional heterogeneity of cytokines and cytolytic effector molecules in human CD8+ T lymphocytes. J Immunol 167:181–187, 2001 Gillespie GM, Wills MR, Appay V, O’Callaghan C, Murphy M, Smith N, : Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8(+) T lymphocytes in healthy seropositive donors. J Virol 74:8140–8150, 2000 Kalams SA, Buchbinder SP, Rosenberg ES, Billingsley JM, Colbert DS, Jones NG, : Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection. J Virol 73:6715–6720, 1999 Sandberg JK, Fast NM, Jordan KA, Furlan SN, Barbour JD, Fennelly G, : HIV-specific CD8+ T cell function in children with vertically acquired HIV-1 infection is critically influenced by age and the state of the CD4+ T cell compartment. J Immunol 170:4403–4410, 2003 Jennes W, Sawadogo S, Koblavi-Deme S, Vuylsteke B, Maurice C, Roels TH, : Positive association between beta-chemokine-producing T cells and HIV type 1 viral load in HIV-infected subjects in Abidjan, Cote d’Ivoire. AIDS Res Hum Retroviruses 18:171–177, 2002 Kamin-Lewis R, Abdelwahab SF, Trang C, Baker A, DeVico AL, Gallo RC, : Perforin-low memory CD8+ cells are the predominant T cells in normal humans that synthesize the beta-chemokine macrophage inflammatory protein-1 beta. Proc Natl Acad Sci USA 98:9283–9288, 2001 Wagner L, Yang OO, Garcia-Zepeda EA, Ge Y, Kalams SA, Walker BD, : Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans. Nature 391:908–911, 1998 Emilie D, Maillot MC, Nicolas JF, Fior R, Galanaud P: Antagonistic effect of interferon-gamma on tat-induced transactivation of HIV long terminal repeat. J Biol Chem 267:20565–20570, 1992 Kornbluth RS, Oh PS, Munis JR, Cleveland PH, Richman DD: Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro. J Exp Med 169:1137–1151, 1989 Oxenius A, Sewell AK, Dawson SJ, Gunthard HF, Fischer M, Gillespie GM, : Functional discrepancies in HIV-specific CD8+ T-lymphocyte populations are related to plasma virus load. J Clin Immunol 22:363–374, 2002 Betts MR, Ambrozak DR, Douek DC, Bonhoeffer S, Brenchley JM, Casazza JP, : Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: Relationship to viral load in untreated HIV infection. J Virol 75:11983–11991, 2001 Addo MM, Yu XG, Rathod A, Cohen D, Eldridge RL, Strick D, : Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J Virol 77:2081–2092, 2003